This is the first examination of the impact of modulating the expression of miR-29b-1-3p and miR-29a-3p on lncRNA abundance in TAM- and fulvestrant-sensitive (MCF-7) versus resistant (LCC9) ER+ BC cells. Here, ESR1 is linked to breast cancer.